CURRENT
ISSUE
1727

Glaucoma is a progressive optic neuropathy associated with increased intraocular pressure (IOP; normal range 8-22 mm Hg), which is the only disease-related factor that can be modified. Topical drugs that lower IOP are the first line of treatment for open-angle glaucoma.

CHOICE OF TOPICAL DRUGS — For initial treatment, topical prostaglandin analog (PGA) monotherapy is preferred. If the PGA lowers IOP into the target range, no additional treatment is necessary. If it substantially decreases IOP but falls short of achieving the target range, another topical drug, such as a beta blocker or a carbonic anhydrase...  Continue reading

Coming Soon
Landiolol (Rapiblyk) for Short-Term Rate Control in Supraventricular Tachycardia
Cologuard Plus — An Updated Stool DNA Test for Colorectal Cancer Screening
Mirikizumab (Omvoh) for Crohn's Disease